Cargando…
PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
Background: Protein arginine methyltransferase 5 (PRMT5) is a type II arginine methyltransferase that symmetrically di-methylates arginine residues on both histone and non-histone protein substrates. Accumulating evidence suggests that PRMT5 exerts its oncogenic properties in a wide spectrum of huma...
Autores principales: | Yang, Liu, Ma, Da-wei, Cao, Yue-peng, Li, Dong-zheng, Zhou, Xin, Feng, Ji-feng, Bao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914347/ https://www.ncbi.nlm.nih.gov/pubmed/33664859 http://dx.doi.org/10.7150/thno.53023 |
Ejemplares similares
-
LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
por: Guo, Mengjun, et al.
Publicado: (2022) -
Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018) -
EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
por: Stefansson, Olafur Andri, et al.
Publicado: (2011) -
PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
por: Wang, Ji, et al.
Publicado: (2023) -
EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
por: Pang, Bo, et al.
Publicado: (2016)